Jinbiao Chen

2.4k total citations
70 papers, 1.4k citations indexed

About

Jinbiao Chen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Jinbiao Chen has authored 70 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 17 papers in Pulmonary and Respiratory Medicine and 10 papers in Immunology. Recurrent topics in Jinbiao Chen's work include Vasculitis and related conditions (13 papers), Sphingolipid Metabolism and Signaling (8 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers). Jinbiao Chen is often cited by papers focused on Vasculitis and related conditions (13 papers), Sphingolipid Metabolism and Signaling (8 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers). Jinbiao Chen collaborates with scholars based in Australia, China and United States. Jinbiao Chen's co-authors include Jennifer R. Gamble, Mathew A. Vadas, Geoffrey W. McCaughan, Yanfei Qi, Pu Xia, Anthony S. Don, Wolfgang Weninger, Ken Liu, Jarem Edwards and Rehana Hewavisenti and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Jinbiao Chen

65 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinbiao Chen Australia 20 622 423 384 152 142 70 1.4k
Hideyuki Komekado Japan 15 737 1.2× 441 1.0× 267 0.7× 84 0.6× 208 1.5× 30 1.4k
Wenfang Tian China 17 588 0.9× 247 0.6× 296 0.8× 67 0.4× 232 1.6× 34 1.1k
Wenting Liu China 18 512 0.8× 212 0.5× 264 0.7× 113 0.7× 231 1.6× 58 1.3k
Youn‐Sang Jung South Korea 21 839 1.3× 309 0.7× 149 0.4× 104 0.7× 130 0.9× 42 1.4k
Wenlin Du Japan 19 554 0.9× 320 0.8× 258 0.7× 89 0.6× 124 0.9× 36 1.1k
Hiromasa Kuroda Japan 20 466 0.7× 573 1.4× 440 1.1× 83 0.5× 311 2.2× 42 1.5k
Qiang Du United States 22 741 1.2× 384 0.9× 397 1.0× 113 0.7× 207 1.5× 40 1.5k
Michiyuki Kanai Japan 19 651 1.0× 598 1.4× 500 1.3× 115 0.8× 136 1.0× 44 1.7k
Minyang Fu China 5 809 1.3× 510 1.2× 496 1.3× 214 1.4× 94 0.7× 7 1.6k

Countries citing papers authored by Jinbiao Chen

Since Specialization
Citations

This map shows the geographic impact of Jinbiao Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinbiao Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinbiao Chen more than expected).

Fields of papers citing papers by Jinbiao Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinbiao Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinbiao Chen. The network helps show where Jinbiao Chen may publish in the future.

Co-authorship network of co-authors of Jinbiao Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Jinbiao Chen. A scholar is included among the top collaborators of Jinbiao Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinbiao Chen. Jinbiao Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shen, Chanjuan, Ting Meng, Wei Lin, et al.. (2024). Clinical features and prognosis of ANCA-associated vasculitis patients who were double-seropositive for myeloperoxidase-ANCA and proteinase 3-ANCA. Clinical and Experimental Medicine. 24(1). 66–66. 3 indexed citations
3.
Dennis, Claude V., Jinbiao Chen, Chuanmin Wang, et al.. (2024). Long-term ex situ normothermic machine perfusion allows regeneration of human livers with severe bile duct injury. American Journal of Transplantation. 25(1). 60–71. 5 indexed citations
4.
Meng, Ting, Wei Lin, Joshua D. Ooi, et al.. (2024). Hydroxychloroquine as an add-on therapy for the induction therapy of MPO-AAV: a retrospective observational cohort study. Clinical Kidney Journal. 17(9). sfae264–sfae264.
5.
Liu, Qixing, Mengna Liu, Jinbiao Chen, Jinlong Wang, & Haifeng Zhou. (2023). Synthesis of Chiral β‐Hydroxy Selenides by Ruthenium‐catalysed Transfer Hydrogenation of α‐Aryl Selenomethyl Ketones. Asian Journal of Organic Chemistry. 12(6). 5 indexed citations
6.
7.
Shen, Chanjuan, Ting Meng, Joshua D. Ooi, et al.. (2022). Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients. Frontiers in Immunology. 13. 991469–991469. 9 indexed citations
8.
Meng, Ting, Chanjuan Shen, Joshua D. Ooi, et al.. (2022). The effect of discontinuation of maintenance therapy in Chinese patients with MPO-ANCA associated vasculitis who were in long-term stable remission. Clinical and Experimental Medicine. 23(2). 357–364. 1 indexed citations
9.
Zhao, Yang, Ka Ka Ting, Paul Coleman, et al.. (2021). The Tumour Vasculature as a Target to Modulate Leucocyte Trafficking. Cancers. 13(7). 1724–1724. 16 indexed citations
10.
11.
Chen, Jinbiao, Ngan Ching Cheng, Ken Liu, et al.. (2021). Deletion of kif3a in CK19 positive cells leads to primary cilia loss, biliary cell proliferation and cystic liver lesions in TAA-treated mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1868(4). 166335–166335. 9 indexed citations
12.
Li, Wei, et al.. (2020). MicroRNA-126 Inhibit Viability of Colorectal Cancer Cell by Repressing mTOR Induced Apoptosis and Autophagy. SHILAP Revista de lepidopterología. 3 indexed citations
13.
Zhao, Yang, Jia Li, Ka Ka Ting, et al.. (2020). The VE-Cadherin/β-catenin signalling axis regulates immune cell infiltration into tumours. Cancer Letters. 496. 1–15. 23 indexed citations
14.
Liu, Ken, Jinbiao Chen, & Geoffrey W. McCaughan. (2020). Animal models for hepatocellular carcinoma arising from alcoholic and metabolic liver diseases. Hepatoma Research. 2020. 6 indexed citations
15.
Zhou, Jian, Shujun Zhang, He Xiao, et al.. (2019). Diagnostic value of angiopoietin-like protein 2 for CHB-related hepatocellular carcinoma. SHILAP Revista de lepidopterología. 1 indexed citations
16.
Xiong, Yan, et al.. (2019). Detection of a novel panel of somatic mutations in plasma cell-free DNA and its diagnostic value in hepatocellular carcinoma. SHILAP Revista de lepidopterología. 2 indexed citations
17.
Edwards, Jarem, James S. Wilmott, Jason Madore, et al.. (2018). CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment. Clinical Cancer Research. 24(13). 3036–3045. 317 indexed citations
18.
Zhao, Yang, Ka Ka Ting, Jia Li, et al.. (2017). Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell–Mediated Immunotherapy. Cancer Research. 77(16). 4434–4447. 50 indexed citations
19.
Chen, Jinbiao, Wei Wang, Yanfei Qi, et al.. (2015). Deletion of sphingosine kinase 1 ameliorates hepatic steatosis in diet-induced obese mice: Role of PPARγ. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1861(2). 138–147. 44 indexed citations
20.
Chen, Jinbiao, et al.. (2015). [Disease spectrum and causes of death in hospitalized children in an upper first-class hospital in Hunan Province, China, from 2010 to 2014].. PubMed. 17(11). 1237–41. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hideyuki Komekado Breakdown of academic impact, for papers by Wenfang Tian Breakdown of academic impact, for papers by Wenting Liu Breakdown of academic impact, for papers by Youn‐Sang Jung Breakdown of academic impact, for papers by Wenlin Du Breakdown of academic impact, for papers by Hiromasa Kuroda Breakdown of academic impact, for papers by Qiang Du Breakdown of academic impact, for papers by Michiyuki Kanai Breakdown of academic impact, for papers by Minyang Fu
Rankless by CCL
2026